One more step towards justifying targeted treatment for insomnia

Affiliations

Comment

Michael L Perlis et al. Sleep. 2011.

. 2011 Apr 1;34(4):417-8.

doi: 10.1093/sleep/34.4.417.

¹ Department of Psychiatry, Behavioral Sleep Medicine Program, University of Pennsylvania, Philadelphia, PA 19104, USA. mperlis@upenn.edu

No abstract available

Comment on

The association between insomnia severity and healthcare and productivity costs in a health plan sample.
Sarsour K, Kalsekar A, Swindle R, Foley K, Walsh JK. Sarsour K, et al. Sleep. 2011 Apr 1;34(4):443-50. doi: 10.1093/sleep/34.4.443. Sleep. 2011. PMID: 21461322 Free PMC article.

1. Smith MT, Perlis ML, Park A, Pennington JY, Orff HJ, Giles DE. Comparative meta-analysis of cognitive-behavioraltherapy and pharmacotherapy for insomnia. Sleep. 2000;23(Supplemental #1):A321–A322.
1. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 1994;151:1172–80. - PubMed
1. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF, III, Kupfer DJ. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 1997;278:2170–7. - PubMed
1. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep. 2005;28:1049–57. - PubMed
1. Fullerton P. The economic impact of insomnia in managed care: a clearer picture emerges. Am J Manag Care. 2006:S246–52. - PubMed